
|Articles|September 1, 2002
Cosmeceuticals are basically 'hope in a jar'
New Orleans - Before solid research establishes their validity, "cosmeceuticals" should be considered "hope in a jar," according to Leslie Baumann, M.D. In discussing the burgeoning field, where cosmetic products are reputed to have biologic effects, Dr. Baumann separated myth from fact at the American Academy of Dermatology annual meeting.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Updates iPLEDGE REMS with New Modifications for Pregnancy Testing and Prescription Windows
2
New Phase 3 DISCREET Data Supports Long-Term Use of Apremilast for Genital Psoriasis
3
Rethinking Aging in Skin of Color: A Pigment-First Approach
4
Phase 3 Results Signal a New Era for Oral Targeted Therapy in Psoriasis
5










